OncoCyte Corp 4
4 · OncoCyte Corp · Filed Feb 18, 2016
Insider Transaction Report
Form 4
MECHEM KRISTINE C.
VP of Marketing
Transactions
- Award
Option to Purchase Common Stock
2016-02-16+60,000→ 60,000 totalExercise: $3.06Exp: 2026-02-15→ Common Stock (60,000 underlying)
Holdings
- 100,000
Option to Purchase Common Stock
Exercise: $3.16Exp: 2025-08-03→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]One quarter of the options shall vest on February 15, 2017, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant.
- [F2]One quarter of the options shall vest on August 3, 2016, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant.